Atai Life Sciences Pre-Paid Expenses 2020-2024 | ATAI

Atai Life Sciences pre-paid expenses from 2020 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
Atai Life Sciences Annual Pre-Paid Expenses
(Millions of US $)
2023 $6
2022 $14
2021 $12
2020 $2
2019 $1
Atai Life Sciences Quarterly Pre-Paid Expenses
(Millions of US $)
2024-09-30 $7
2024-06-30 $5
2024-03-31 $6
2023-12-31 $6
2023-09-30 $7
2023-06-30 $6
2023-03-31 $9
2022-12-31 $14
2022-09-30 $13
2022-06-30 $11
2022-03-31 $13
2021-12-31 $12
2021-09-30 $12
2021-06-30 $4
2021-03-31 $4
2020-12-31 $2
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.255B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.347B 11.70
Quest Diagnostics (DGX) United States $18.293B 18.54
DaVita (DVA) United States $13.459B 17.41
Encompass Health (EHC) United States $10.015B 23.61
Chemed (CHE) United States $8.477B 26.05
Elanco Animal Health (ELAN) United States $6.624B 15.77
RadNet (RDNT) United States $6.018B 133.28
Option Care Health (OPCH) United States $3.827B 18.14
Amedisys (AMED) United States $2.953B 21.02
LifeStance Health (LFST) United States $2.797B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.191B 25.71
U.S Physical Therapy (USPH) United States $1.463B 38.47
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.048B 42.36
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.008B 0.00
ATI Physical Therapy (ATIP) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00